Avitar, Inc. (AVTI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 10, 2025, 8:00 PM EDT
Verve Therapeutics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 1999 - 2003 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '07 Dec 31, 2007 | Sep '07 Sep 30, 2007 | Sep '06 Sep 30, 2006 | Sep '05 Sep 30, 2005 | Sep '04 Sep 30, 2004 | Sep '03 Sep 30, 2003 | 1999 - 2003 |
| 2.66 | 3.11 | 4.52 | 4.51 | 4.05 | 4.6 | Upgrade | |
Revenue Growth (YoY) | -41.61% | -31.26% | 0.22% | 11.37% | -11.95% | -44.55% | Upgrade |
Cost of Revenue | 2.04 | 2.27 | 3.14 | 3.18 | 2.71 | 3.43 | Upgrade |
Gross Profit | 0.62 | 0.84 | 1.37 | 1.33 | 1.34 | 1.16 | Upgrade |
Selling, General & Admin | 3.15 | 3.26 | 3.77 | 4.33 | 3.4 | 3.6 | Upgrade |
Research & Development | 0.31 | 0.31 | 0.49 | 0.72 | 0.56 | 0.76 | Upgrade |
Operating Expenses | 3.46 | 3.57 | 4.27 | 5.05 | 3.97 | 4.37 | Upgrade |
Operating Income | -2.84 | -2.73 | -2.89 | -3.73 | -2.63 | -3.2 | Upgrade |
Interest Expense | -1.56 | -1.44 | -0.86 | -0.12 | -0.26 | -1.72 | Upgrade |
Other Non Operating Income (Expenses) | 1.79 | 1.97 | 0.2 | 1.52 | 0.56 | -0.03 | Upgrade |
EBT Excluding Unusual Items | -2.61 | -2.2 | -3.55 | -2.33 | -2.33 | -4.95 | Upgrade |
Impairment of Goodwill | - | - | - | -0.1 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.02 | Upgrade |
Other Unusual Items | - | - | - | - | -0.07 | - | Upgrade |
Pretax Income | -2.61 | -2.2 | -3.55 | -2.43 | -2.4 | -4.93 | Upgrade |
Earnings From Continuing Operations | -2.61 | -2.2 | -3.55 | -2.43 | -2.4 | -4.93 | Upgrade |
Earnings From Discontinued Operations | -0.03 | -0.06 | -0.15 | - | -0.01 | -0.88 | Upgrade |
Net Income | -2.65 | -2.26 | -3.7 | -2.43 | -2.41 | -6.46 | Upgrade |
Preferred Dividends & Other Adjustments | 0.15 | 0.15 | 0.16 | 2.34 | 1.86 | 1.67 | Upgrade |
Net Income to Common | -2.8 | -2.41 | -3.87 | -4.78 | -4.27 | -8.14 | Upgrade |
Shares Outstanding (Basic) | 45 | 26 | 5 | 3 | 2 | 1 | Upgrade |
Shares Outstanding (Diluted) | 45 | 26 | 5 | 3 | 2 | 1 | Upgrade |
Shares Change (YoY) | 570.47% | 445.89% | 55.69% | 46.05% | 55.82% | 60.40% | Upgrade |
EPS (Basic) | -0.06 | -0.09 | -0.80 | -1.53 | -2.00 | -5.94 | Upgrade |
EPS (Diluted) | -0.06 | -0.09 | -0.80 | -1.53 | -2.00 | -5.94 | Upgrade |
Free Cash Flow | -2.01 | -1.79 | -2.82 | -4.22 | -3.75 | -2.46 | Upgrade |
Free Cash Flow Per Share | -0.04 | -0.07 | -0.58 | -1.35 | -1.76 | -1.80 | Upgrade |
Gross Margin | 23.36% | 26.94% | 30.42% | 29.41% | 32.98% | 25.34% | Upgrade |
Operating Margin | -106.51% | -87.98% | -64.02% | -82.67% | -64.97% | -69.66% | Upgrade |
Profit Margin | -104.99% | -77.64% | -85.53% | -105.93% | -105.53% | -176.96% | Upgrade |
Free Cash Flow Margin | -75.38% | -57.62% | -62.29% | -93.53% | -92.75% | -53.52% | Upgrade |
EBITDA | -2.74 | -2.61 | -2.75 | -3.58 | -2.51 | -3.03 | Upgrade |
EBITDA Margin | -102.82% | -84.16% | -60.84% | -79.40% | -62.09% | -65.98% | Upgrade |
D&A For EBITDA | 0.1 | 0.12 | 0.14 | 0.15 | 0.12 | 0.17 | Upgrade |
EBIT | -2.84 | -2.73 | -2.89 | -3.73 | -2.63 | -3.2 | Upgrade |
EBIT Margin | -106.51% | -87.98% | -64.02% | -82.67% | -64.97% | -69.66% | Upgrade |
Advertising Expenses | - | - | - | 0 | - | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.